ProCE Banner Activity

Mpox in Advanced HIV: A New AIDS-Defining Condition in the Americas and Beyond?

Conference Coverage
Clinical Thought

People with HIV have been disproportionately affected by mpox, and the international SHARE collaborative network has given us key insights on outcomes in this population.

Released: March 14, 2023

Expiration: March 12, 2024

No longer available for credit.



Beatriz Grinsztejn

Beatriz Grinsztejn, MD, PhD

STI/AIDS Clinical Research Laboratory, Director
Instituto Nacional de Infectologia Evandro Chagas
Rio de Janeiro, Brazil


Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare


Beatriz Grinsztejn, MD, PhD: consultant/advisor/speaker: Janssen, Merck, ViiV.